Autopsy report · NCT05017584

ED90 of 0.75% Bupivacaine for Bilateral Tubal Ligation (BTL)

“Study halted prematurely, prior to enrollment of first participant”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Duke University

Sponsor type

University, hospital or other

Conditions

Pain

Interventions

Hyperbaric bupivacaine

Participants

0

Trials that died the same way

• Tiotropium Handihaler vs. Tiotropium Respimat in COPD
  “Study halted prematurely due to funding, prior to enrollment of first participant” (93% match in meaning)
• High Cut Off Dialysis in Systemic Inflammatory Response Syndrome Patients After Cardiac Surgery
  “Study halted prematurely, prior to enrollment of first patient, due to recruiting problems.” (87% match in meaning)
• Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma
  “Withdrawn: study halted prematurely, prior to enrollment of first participant” (85% match in meaning)
• An Exploratory Clinical Study of GC012F Injection for Refractory gMG
  “The study stopped early, before enrolling its first participant.” (84% match in meaning)
• Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
  “The study was halted because enrollment was too slow” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.